Clinica    Scrip    Scrip Regulatory Affairs    Scrip Clinical Research    Animal Pharm   
Email ID
Password
Forgotten password?
Sign me in automatically next time
Home
Market Sector
Business
Policy & Regulation
Regions
Deals
|
M & A
|
Financials
|
Funding
|
Legal
|
Start-ups & SMEs
|
Market Monitor
|
clinica
Business
French allergy company DBV takes first step towards 2012 IPO
03 February 2012
Allergy treatment specialist DBV Technologies is planning an initial public offering on the NYSE Euronext exchange this year. The company has taken the first step of filing its “Document de Base” with the French Autorité des marchés financiers ...
 
Lab21 gains new platform for developing molecular Dx faster
26 January 2012
UK personalised medicine specialist Lab21 has struck a worldwide licensing deal with Cooperative Diagnostics, giving it exclusive access to real-time PCR technology that should allow it to fast-track the development of its molecular diagnostics ...
Genzyme and Veracyte in personalised medicine tie-up for thyroid cancer
24 January 2012
Sanofi 's Genzyme and molecular diagnostics company Veracyte have entered into a global co-promotion agreement that taps into Genzyme's endocrinology sales force and marketing infrastructure to help speed up commercialisation of Veracyte's ...
 
Canon enters medical informatics with Delft acquisition
03 February 2012
Canon Europe, part of the Japanese imaging and camera specialist Canon , has bought Dutch firm Delft Diagnostic Imaging, expanding its X-ray capabilities and giving it a foothold in the medical informatics market. Financial terms of the deal were ...
Terumo gains new minimally-invasive sheath tech with Onset acquisition
17 January 2012
Terumo Americas has bolstered its presence in the access sheath segment by acquiring Onset Medical, a company that claims to have developed the smallest sheath profiles with the largest available internal diameters. The devices are used in multiple ...
 
Quarterly results round-up: Getinge and Philips look to restructuring to save costs
02 February 2012
Swedish medtech firm Getinge beat analysts' estimates in its fourth fiscal quarter due to "strong margin improvements", according to Jefferies analyst Ingeborg Øie. Q4 net sales were up 11% to SEK7.35bn ($1.09bn), while net income also increased to ...
Quarterly results round-up: “no better, no worse” for Bard, Roche suffers from exchange rates again
01 February 2012
CR Bard has seen its bottom line shrink 16% to $113.8m during its fourth fiscal quarter as it absorbed charges relating to acquisitions, as well as restructuring and legal fees. Q4 net sales were up 5% year-on-year to $751.9m, with a stronger ...
 
French allergy company DBV takes first step towards 2012 IPO
03 February 2012
Allergy treatment specialist DBV Technologies is planning an initial public offering on the NYSE Euronext exchange this year. The company has taken the first step of filing its “Document de Base” with the French Autorité des marchés financiers ...
Quintiles invests in cancer biomarker start-up
26 January 2012
Quintiles has invested £3m ($4.7m) in a new company formed in partnership with the University of Oxford and two of its professors, which will provide oncology consulting services and new cancer biomarkers to clients for personalised medicine ...
 
J&J suffers knock-back in drug-eluting stent wars
26 January 2012
Johnson & Johnson was dealt a blow recently in its courtroom wrangling with rival heart stent makers Abbott, Boston Scientific and Medtronic over patents relating to the devices' drug coating. Last week, a US district court judge in New Jersey ...
More hip trouble on horizon for DePuy as Pinnacle Ultamet patient sues?
24 January 2012
Johnson & Johnson subsidiary DePuy Orthopaedics may be facing more problems with its metal-on-metal (MoM) hip implants, after a patient receiving its Pinnacle Ultamet device sued the company. DePuy told Clinica that it "stands firmly behind the ...
 
Quintiles invests in cancer biomarker start-up
26 January 2012
Quintiles has invested £3m ($4.7m) in a new company formed in partnership with the University of Oxford and two of its professors, which will provide oncology consulting services and new cancer biomarkers to clients for personalised medicine ...
Q3 venture financing round-up: IVD back on top, surgery also gets a boost
13 December 2011
Some 70 medtech venture financing deals that raised over $1m passed Clinica's news desk in the third quarter of 2011, a significant increase from the 52 deals we saw in the previous quarter. Helping to boost the volume of financing deals is ...
 
Will Sunshine rise in heart assist market outside US in 2012?
20 December 2011
Tina Tan

Sunshine Heart is readying itself to launch its C-Pulse heart assist system in Europe in the second quarter next year, as it clears the final hurdles for its CE mark application this week. Speaking to Clinica in a telephone interview on 16 ...

 
Softening CRM sector in need of more pace and rhythm
03 February 2012
Ashley Yeo

Cardiac rhythm management remains a $2bn business at Boston Scientific , but a 15% slide (in both reported and constant currencies) in sales in the final quarter of 2011, reported yesterday, meant that the group’s second-largest business unit ...

 
Softening CRM sector in need of more pace and rhythm
03 February 2012
Cardiac rhythm management remains a $2bn business at Boston Scientific , but a 15% slide (in both reported and constant currencies) in sales in the final quarter of 2011, reported yesterday, meant that the group’s second-largest business unit ...
 Quarterly results round-up: Abbott staying conservatively op...   Boston launches two new defib families in Europe; offers US ...
Refurbishment and reprocessing - threat or opportunity for medical device manufacturers?
31 January 2012
Medical device refurbishment – restoring devices to their original specifications – has gained in importance as healthcare budgets have come under pressure. While some countries actively ban imports of such devices, attitudes generally towards the ...
Today Illumina; tomorrow the world? Where the acquisition might really take Roche
26 January 2012
Hoffmann-La Roche wants to acquire the San Diego-based gene sequencing and array diagnostic company Illumina, and the fact that it is willing to engage in a hostile takeover of the company and start the bidding in that process at a 64% premium to ...

Eucomed MTF 2011: “New medtech business models required, but where are the opportunities?” – PwC
18 October 2011
Amanda Maxwell

In medical technology, business innovation is moving the industry more towards services, like IT did 20 years ago. Many companies, however, are ill prepared to make the paradigm shift that is required in creating new service-led products; many ...

 
Clinica 100
28 October 2011

This year's Clinica 100: Analysis of the Medtech Industry is now out with the December issue. This special 24-page section features: - Clinica League Tables - Top 100 medtech companies and Top 20 Sector Leaders - Interviews offering insight into ...

 
EVENTS
The 14th MedTech Investing Europe conference
19 March 2012
Montreux Convention and Music Centre, Switzerland
HTAi 2012
23 June 2012
Bilbao, Spain
 
© 2012 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36
Home
Market Sector
Business
Policy & Regulation
Regions
Terms & Conditions
Privacy Policy
Sitemap
About Us
Advertise
Subscribe
Clinica
Scrip
Scrip Regulatory Affairs
Scrip Clinical Research
Animal Pharm